• ScreenPro (SCRN) has entered into an LOI to acquire Concierge Medical Consultants from Datametrex AI (DM)
  • Concierge Medical Consultants provides on-call urgent care, COVID testing and occupational medical consulting services
  • ScreenPro will pay C$1,800,000 for the acquisition through the issuance of common shares
  • The parties intend to enter into a definitive agreement by no later than November 30, 2021
  • ScreenPro Security is a medical technology company that offers proprietary testing methods and medical alerting software
  • ScreenPro (SCRN) is unchanged trading at $0.02 per share

ScreenPro (SCRN) has entered into an LOI to acquire Concierge Medical Consultants from Datametrex AI (DM).

Concierge Medical Consultants is a small group of board-certified emergency physicians who provide on-call urgent care, COVID testing and occupational medical consulting services.

The company’s founder and CEO, Dr. Jibran Sharif, MD, CCFP EM, RDMS, is a full-time emergency physician in Metro Vancouver and a lecturer with the faculty of Emergency Medicine at the University of British Columbia.

Pursuant to the LOI, ScreenPro will pay C$1,800,000 for the acquisition through the issuance of common shares priced at $0.05 per share.

The parties intend to enter into a definitive agreement by no later than November 30, 2021.

Lena Kozovski, CEO of ScreenPro Security, stated,

“We believe that adding a medical concierge element to our existing businesses will drive significant value to our bottom line as we have the infrastructure with laboratories, nurses, back-office and scheduling systems in place now with our testing.

The demand for concierge medical services is expected to continue to strengthen as the market for remote health care grows. We look forward to working with Dr. Sharif and his medical team to grow this business under ScreenPro.”

ScreenPro Security is a medical technology company that offers proprietary testing methods and medical alerting software.

ScreenPro (SCRN) is unchanged trading at $0.02 per share as of 9:30 am ET.

More From The Market Online

Calian scores $23 million Canadian Armed Forces contract

Calian Group Ltd. (TSX:CGY) has been awarded a $17 million contract by the Canadian Armed Forces’ Canadian Forces Health Services Group.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

This life sciences company is gearing up to treat long COVID  

Revive Therapeutics (CSE:RVV), a Toronto-based company, has immense potential to capitalize on treating long COVID symptoms.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.